Michael Twahier Nurmohamed
Michael Twahier Nurmohamed publishes mostly in Rheumatology, Immunology and Cardiology and Cardiovascular Medicine, on topics such as Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments and Systemic Lupus Erythematosus Research.
- World rank
- #219,958 of 7,710,434 ranked researchers
- Rank in Netherlands
- #5,577 of 107,149
- Works
- 636
- Citations
- 21k
- Citations per work
- 33.7
What does Michael Twahier Nurmohamed research?
Michael Twahier Nurmohamed's work is mostly in Medicine (57%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences36056.6%
- Medicine36056.6%
- Everything else22435.2%
- Life Sciences528.2%
- 1Rheumatology42% of their works
- 2Immunology8% of their works
- 3Cardiology and Cardiovascular Medicine4% of their works
- 4Hematology4% of their works
- 5Pathology and Forensic Medicine3% of their works
- 6Surgery3% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Autoimmune and Inflammatory Disorders Research
- Biosimilars and Bioanalytical Methods
- Psoriasis: Treatment and Pathogenesis
- Gout, Hyperuricemia, Uric Acid
- Monoclonal and Polyclonal Antibodies Research
Which keywords describe Michael Twahier Nurmohamed's research?
The keywords of their largest research topics: Autoantibodies, Cardiovascular Risk, Inflammation, Biological Therapy, Rheumatoid Arthritis, Ankylosing Spondylitis, Spondyloarthritis and Antiphospholipid Syndrome.
- Therapeutic Antibodies
- Uric Acid
- TH17 Cells
- Immunogenicity
- Juvenile Idiopathic Arthritis
- Monoclonal Antibodies
- Antiphospholipid Syndrome
- Ankylosing Spondylitis
- Biological Therapy
- Cardiovascular Risk
- Autoantibodies
- Inflammation
- Rheumatoid Arthritis
- Spondyloarthritis
- Systemic Lupus Erythematosus
- Hemophagocytic Lymphohistiocytosis
- Biosimilars
- IL-17
- Hyperuricemia
- Fc Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Autoantibodies5402 topics
- Cardiovascular Risk4542 topics
- Inflammation4542 topics
- Biological Therapy4121 topic
- Rheumatoid Arthritis4121 topic
- Ankylosing Spondylitis1771 topic
- Spondyloarthritis1771 topic
- Antiphospholipid Syndrome1281 topic
- Systemic Lupus Erythematosus1281 topic
- Monoclonal Antibodies962 topics
- Hemophagocytic Lymphohistiocytosis571 topic
- Juvenile Idiopathic Arthritis571 topic
- Biosimilars551 topic
- Immunogenicity551 topic
- IL-17441 topic
- TH17 Cells441 topic
- Hyperuricemia421 topic
- Uric Acid421 topic
- Fc Receptors411 topic
- Therapeutic Antibodies411 topic
Where does Michael Twahier Nurmohamed work?
Michael Twahier Nurmohamed's main affiliation in the publication record is Reade, Netherlands.
How many publications and citations does Michael Twahier Nurmohamed have?
OpenAlex counts 636 works and 21,406 citations for Michael Twahier Nurmohamed, an h-index of 70, ranking #219,958 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael Twahier Nurmohamed. Posts are plain text and can be reported.